Noticias de investigación
Ver artículos por meses y años
1–9 of 9 artículos
-
Drug May Boost Survival in Metastatic Breast Cancer (en inglés)
Women diagnosed with metastatic breast cancer that had stopped responding or failed to respond to other treatments lived 2 months longer when treated with Halavan (chemical name: eribulin) compared to ...
-
FDA Approves Drug for Pretreated Breast Cancer (en inglés)
The U.S. Food and Drug Administration (FDA) has approved a new chemotherapy medicine, Halaven (chemical name: eribulin), to treat metastatic breast cancer that already has been treated with other chemo...
-
ASCO Breast: Analysis Revises Taxane Benefit in Breast Cancer (en inglés)
After surgery for early-stage breast cancer, chemotherapy often is given to destroy any breast cancer cells that may remain in the body and reduce the risk of the cancer coming back (recurrence). Docto...
-
New Chemotherapy Agents Cut Advanced Breast Cancer Mortality in Half (en inglés)
Research has made it clear that new ways to treat and diagnose breast cancer have benefitted women diagnosed with early-stage breast cancer. Women diagnosed with advanced-stage breast cancer also have ...
-
Breast Cancer Benefit Seen for Bevacizumab Combo (en inglés)
Xeloda (chemical name: capecitabine) is a chemotherapy medicine used to treat advanced (metastatic) breast cancer. A study found that a combination of Xeloda and Avastin (chemical name: bevacizumab), a...
-
Paclitaxel improves early breast cancer survival (en inglés)
A large study looked at more than 1,200 women who had surgery to treat early-stage breast cancer that had spread to nearby lymph nodes. After surgery, all of the women got a particular combination of c...
-
Weekly Taxol best for followup breast cancer care (en inglés)
A study found that getting Taxol (chemical name: paclitaxel) weekly had more benefits than getting Taxol every 3 weeks for women diagnosed with breast cancer that had spread to the lymph nodes or women...
-
Breast cancer survival longer with Taxotere: study (en inglés)
The combination of two chemotherapy medicines, Adriamycin (chemical name: doxorubicin) and Cytoxan (chemical name: cyclophosphamide), often referred to as AC, is commonly used after surgery to treat an...
-
Some women can reduce breast cancer chemo: study (en inglés)
After surgery to remove early breast cancer, a combination of chemotherapy medicines is usually recommended to reduce the risk of the cancer coming back (recurrence). One common combination is Adriamyc...
1–9 of 9 artículos
